White House Drafts Order to Oversee NIH Grant Allocations

By Rachel Kim

The White House is preparing an executive order that would introduce an external panel to oversee National Institutes of Health (NIH) grants, according to federal officials. This move is designed to align grant allocations with presidential priorities, potentially altering the traditional peer-review process that has guided NIH funding decisions.

The Office of Management and Budget (OMB) is spearheading the effort, which was discussed at a White House meeting on September 18, 2026. The proposed panel would have the authority to veto grants that do not conform to the administration's objectives.

NIH's current budget stands at approximately $48 billion, funding research in critical areas such as cancer, heart disease, and infectious diseases. Historically, these funds have been distributed based on scientific merit as determined by expert peer review.

NIH spokesperson Joshua Pradko assured that no funds would be rescinded under the new proposal, stating, “There will be no rescissions to N.I.H. grant monies. All N.I.H. grant monies will be spent.”

This initiative follows a previous executive order from August 2025, which mandated senior appointee sign-offs on grant announcements, required subject-matter expert reviews, and ensured that awards align with national interests.